Universe Pharmaceuticals Inc (UPC): Capital Expenditures

Annual figures by period end, from SEC filings.

Figures out of scale. In this company's filings, reported revenue for the year ended 2023-09-30 is more than 100 times total assets. That usually means a value was tagged in the wrong unit. Figures are shown as filed; growth rates are not computed, and the company is left out of screens and comparisons.

$266.77M
Year ended 2025-09-30. As filed; likely tagged in the wrong unit
2019-09-30: $86.3K2020-09-30: $51.8K2021-09-30: $444.5K2022-09-30: $93.7K2023-09-30: $44.17M2024-09-30: $208.32M2025-09-30: $266.77M$266.77M
2019-09-30 Capital Expenditures (USD) 2025-09-30
Period endedCapital ExpendituresChange YoYSource filing
2025-09-30$266.77Mn/a2026-01-29, From 2024-10-01
2024-09-30$208.32Mn/a2026-01-29, From 2023-10-01
2023-09-30$44.17Mn/a2026-01-29, From 2022-10-01
2022-09-30$93.7Kn/a2025-04-29, From 2021-10-01
2021-09-30$444.5Kn/a2024-01-30, From 2020-10-01
2020-09-30$51.8Kn/a2023-02-10, From 2019-10-01
2019-09-30$86.3Kn/a2022-01-31, From 2018-10-01